Dietary cholesterol reverses resistance to diet-induced weight gain in mice lacking Niemann-Pick C1-Like 1

Gastrointestinal regulatory peptides and their effects on fat tissue

(2016) Ishita D Majumdar et al.   Current Opinion in Endocrinology Diabetes and Obesity

Ezetimibe Ameliorates Metabolic Disorders and Microalbuminuria in Patients with Hypercholesterolemia

(2011) Shusuke Yagi et al.   Journal of Atherosclerosis and Thrombosis

Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease

(2009) Yuichi Nozaki et al.   JOURNAL OF HEPATOLOGY

The core gut microbiome, energy balance and obesity

(2009) Peter J. Turnbaugh et al.   JOURNAL OF PHYSIOLOGY-LONDON

Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1−/− mice

(2008) Eric D. Labonté et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Niemann-Pick C1-Like 1 Is Required for an LXR Agonist to Raise Plasma HDL Cholesterol in Mice

(2008) Weiqing Tang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Transcriptional Regulation of HMG-CoA Synthase and HMG-CoA Reductase Genes by Human ACBP

(2008) Christina Vock et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice

(2008) Shuqin Zheng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8

(2008) Weiqing Tang et al.   JOURNAL OF LIPID RESEARCH

Extracellular loop C of NPC1L1 is important for binding to ezetimibe

(2008) A. B. Weinglass et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA